Press Releases
San Francisco, CA., May 21, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on June 3, 2013, to discuss the Company’s financial results for the fourth quarter and full year of fiscal 2013 and to provide an update about the [...]
San Francisco, CA and Boston, MA, May 8, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing the clinical interpretation of molecular diagnostic testing, and GeneInsight LLC., a leading developer of software to support knowledge management and reporting for genetic testing laboratories, today announced an agreement to deliver a unique medical [...]
San Francisco, Calif., April 9, 2013 – CollabRx, Inc. (NASDAQ: CLRX), today announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic decision making solutions for Asian and global markets. Sengenics plans to incorporate CollabRx’s interpretive content resources into its molecular cancer diagnostics tests and reports. “Sengenics has become a widely [...]
San Francisco, Calif., April 4, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and OncoDNA, SA, a Belgium company that provides DNA next generation sequencing (NGS) tests for clinical use in cancer, today announced a multi-year agreement to purchase CollabRx SaaS-based technology and content [...]
Razelle Kurzrock, M.D., named as Chief Editor San Francisco, Calif., March 26, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the formation of a Pan Cancer (biomarker-focused) molecular oncology editorial board to be led by Razelle Kurzrock, M.D., who will serve as [...]
San Francisco, Calif., March 4, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Projects In Knowledge, Inc., a leading developer of point-of-care digital and mobile information tools and continuing medical education (CME/CE) programs, today announced a multi-year partnership agreement to jointly distribute informational [...]
E. David Crawford, M.D. named as Chief Editor San Francisco, Calif., February, 19, 2013 – CollabRx, Inc. (NASDAQ: CLRX) today announced the formation of an editorial board for prostate cancer to be led by E. David Crawford, M.D. who will serve as Chief Editor. Dr. Crawford is the distinguished Professor of Surgery, Urology, and Radiation [...]
San Francisco, Calif., February 12, 2013 – CollabRx, Inc. (the “Company”) (NASDAQ: CLRX) today announced financial results for the Third Quarter Fiscal Year 2013, which ended December 31, 2012. Fiscal 2013 Second Quarter Financial Statement Highlights The Company’s Net Loss per share in the Third Quarter of Fiscal 2013 was $(0.61), compared with Net Income [...]
SAN FRANCISCO, Feb. 7, 2013 – CollabRx, Inc. (Nasdaq:CLRX) today announced the release of a new version of its Therapy Finder™application (“app”) for lung cancer. The lung cancer Therapy Finder™app is a web-based decision support tool that enables oncologists to take into account the genetics of a patient’s tumor when determining a treatment plan. The [...]
San Francisco, CA., February 5, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February 12, 2013, to discuss the Company’s financial results for the third quarter of fiscal 2013 and to provide an update to the business. The dial-in [...]
